In general, our findings support the initial theory of Ito et al. assuming that the anti-obesity effect of MCHR1 antagonists is not limited to a central action, but MCHR1 antagonists may also act peripherally in BAT (21). Here, MCHR1 is linked to obesity due to melanocortin 4 receptor deficiency.